Survey: pandemic viewed as catalyst for positive change in trials
According to a recent survey from Oracle Health Sciences, 97% of trial professionals say newly adopted approaches will stay in use as we move beyond COVID-19.
Archives for October 26, 2021
Potential COVID-19 treatment to wrap up Phase III trial
Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.